MacuLogix Revenue and Competitors
Estimated Revenue & Valuation
- MacuLogix's estimated annual revenue is currently $2.1M per year.
- MacuLogix received $38.7M in venture funding in March 2019.
- MacuLogix's estimated revenue per employee is $125,500
- MacuLogix's total funding is $64.3M.
Employee Data
- MacuLogix has 17 Employees.
- MacuLogix grew their employee count by -78% last year.
MacuLogix's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Marketing | Reveal Email/Phone |
2 | Director Product Innovation | Reveal Email/Phone |
3 | Sr. Director Operations | Reveal Email/Phone |
4 | Director Software Engineering | Reveal Email/Phone |
5 | Manager, Practice Management in Customer Success | Reveal Email/Phone |
6 | Manager Logistics | Reveal Email/Phone |
7 | Sr. Manager, Professional Relations | Reveal Email/Phone |
8 | Regional Sales Executive | Reveal Email/Phone |
9 | Regional Sales Executive | Reveal Email/Phone |
10 | President & CEO | Reveal Email/Phone |
MacuLogix Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $73.5M | 293 | 12% | N/A | N/A |
#2 | $7M | 28 | -10% | N/A | N/A |
#3 | $37.9M | 151 | 13% | N/A | N/A |
#4 | $2.1M | 17 | -78% | $64.3M | N/A |
#5 | $9.3M | 37 | -10% | N/A | N/A |
#6 | $56.2M | 179 | 0% | N/A | N/A |
#7 | $38.9M | 155 | -1% | N/A | N/A |
#8 | $22.1M | 88 | 5% | N/A | N/A |
#9 | $22.1M | 88 | 9% | N/A | N/A |
#10 | $33.4M | 133 | 10% | N/A | N/A |
What Is MacuLogix?
MacuLogix is the only company to leverage the science of dark adaptation to help eliminate preventable blindness caused by AMD. Through its AdaptDx® dark adaptometer, MacuLogix enables eye care professional to detect, monitor and start treating AMD three years before it can be seen in order to prevent vision loss. MacuLogix provides in-practice training and best practices to support the effective and efficient implementation and use of the AdaptDx
keywords:Biotechnology,Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals$64.3M
Total Funding
17
Number of Employees
$2.1M
Revenue (est)
-78%
Employee Growth %
N/A
Valuation
N/A
Accelerator
MacuLogix News
The AdaptDx (MacuLogix) is a functional testing device that has been shown in clinical trials to identify patients with the earliest stages of AMD even when they ...
MacuLogix has completed $38.7 million in Series D financing led by Vivo ... of funding brings MacuLogix's venture funding total to $51 million.
MacuLogix, a Harrisburg, Pennsylvania-based company that equips eye care professionals with the instruments, tools, and education they need to effectively diagnose and treat patients with age-related macular degeneration (AMD), has raised $38.7 million in Series D funding. This round of funding ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.5M | 17 | N/A | N/A |
#2 | $1M | 17 | -26% | N/A |
#3 | $35M | 19 | 6% | N/A |
#4 | $2.9M | 20 | 0% | N/A |
#5 | $4.1M | 20 | -17% | N/A |
MacuLogix Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2013-03-12 | $3.6M | A | Multiple | Article |
2015-08-04 | $5.0M | Undisclosed | Article | |
2018-07-20 | $10.0M | Undisclosed | Horizon Technology Finance Corporation | Article |
2019-03-05 | $38.7M | D | Vivo Capital | Article |